Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Revance Therapeutics Inc.

Start price
Target price
Perf. (%)
€30.40
24.01.23
-
24.01.24
-82.57%
25.01.24

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€43.80
24.12.23
€100.00
28.02.26
73.52%
25.01.24

Could be very worthwhile Investment >20% year
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€244.00
23.01.23
€150.00
23.01.24
-38.11%
24.01.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.60
27.12.23
-
27.12.24
12.33%
21.01.24

Could be very worthwhile Investment >20% year
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.95
18.01.24
-
18.01.25
-14.44%
21.01.24

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.98
18.01.24
-
18.01.25
-3.63%
20.01.24

Could be worthwhile Investment >10% per year
buy
Seres Therapeutics Inc

Start price
Target price
Perf. (%)
€1.32
09.01.24
-
09.01.25
-6.06%
20.01.24

Could be worthwhile Investment >10% per year
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€18.20
07.08.23
-
07.08.24
224.18%
19.01.24

Probably not worthwhile Investment
Kezar Life Sciences

Start price
Target price
Perf. (%)
€1.13
19.08.23
-
19.08.24
-37.17%
19.01.24

Probably not worthwhile Investment
Brainstorm Cell

Start price
Target price
Perf. (%)
€1.29
19.08.23
-
19.08.24
-80.16%
19.01.24

Probably not worthwhile Investment
Cytosorbents Corp.

Start price
Target price
Perf. (%)
€1.83
17.09.23
-
17.09.24
-52.14%
19.01.24

Probably not worthwhile Investment
Novavax Inc.

Start price
Target price
Perf. (%)
€11.01
11.01.23
€6.00
11.01.24
-61.64%
12.01.24

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.12
24.06.23
€2.30
31.03.26
51.79%
08.01.24

Could be very worthwhile Investment >20% year
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€2.64
28.12.23
-
28.12.24
-9.11%
06.01.24

Risky Investment
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.20
24.12.23
-
24.12.24
1.36%
06.01.24

Could be worthwhile Investment >10% per year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.60
27.12.23
€3.00
27.12.24
13.68%
28.12.23

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€2.90
22.12.23
-
22.12.24
-17.24%
26.12.23

Could be worthwhile Investment >10% per year
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.19
24.12.22
-
24.12.23
5.50%
25.12.23

Could be worthwhile Investment >10% per year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€32.80
10.12.23
€55.00
30.06.25
33.54%
24.12.23

Could be very worthwhile Investment >20% year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€2.09
22.12.23
-
22.12.24
9.11%
23.12.23

Could be worthwhile Investment >10% per year
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.84
14.12.23
-
14.12.24
23.78%
23.12.23

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.04
10.12.23
-
10.12.24
70.52%
23.12.23

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€82.00
02.02.21
€85.00
01.02.24
-96.49%
20.12.23

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Innovative
scPharmaceuticals

Start price
Target price
Perf. (%)
€4.66
13.11.23
-
13.11.24
12.66%
11.12.23

Probably not worthwhile Investment
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€4.66
13.11.23
-
13.11.24
0.86%
11.12.23

Probably not worthwhile Investment